OCIAD2 as a novel prognostic and therapeutic biomarker for pancreatic cancer: A study based on transcriptomic signature and bioinformatics analysis

Zhongyuan Cui, Xia Lei, Yani Gou, Zhixian Wu, Xiaojun Huang. OCIAD2 as a novel prognostic and therapeutic biomarker for pancreatic cancer: A study based on transcriptomic signature and bioinformatics analysis. PLoS Computational Biology, 21(10):1013566, 2025. [doi]

References

No references recorded for this publication.

Cited by

No citations of this publication recorded.